Zoetis Inc., ZTS is in the exchange NYSE and its industry is Drugs – Generic in the sector of Healthcare. Based in USA, Zoetis Inc., ZTS has a market cap of 25471.85. Since its IPO date on the 2/1/2013, Zoetis Inc., ZTS performance year to date is 7.55%. Today Zoetis Inc., ZTS has gained 0.98%, with a current price of 51.71.
Ownership of the company is 0.01% for insider ownership while institutional ownership is 91.30%. The management of the company have seen the company have a payout ratio of 46.90%. Return of assets are at 5.30%, with return on investment at 5.70%.
In terms of debt levels and profit levels, Zoetis Inc., ZTS is seeing a long-term debt/equity of 3.83. While Total debt/equity is 3.84. With a profit margin of 7.80%, this is combined with a gross margin of 64.10%, and operating margin of 13.40%. Zoetis Inc. ability to meet debt levels, with a current ratio of 2.8, while the quick ratio is 1.6.
For the last year Zoetis Inc., ZTS has seen a EPS growth of -41.90%. A performance for the year of 5.88%. The 52-week high is -0.90%, and the 52-week low is 38.19%. The average volume for Zoetis Inc., ZTS is 2110625.
With a target price of 54, can Zoetis Inc., ZTS reach this target? Looking at the value indicators of Zoetis Inc., ZTS. Zoetis Inc. has a P/E of 67.65 and a forward P/E of 22.28. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.38. Zoetis Inc. also has a P/S and a P/B of 5.28 and 21.88 respectively. For P/cash, Zoetis Inc. has a value of 37.74, while it is 89.37 for P/free cash flow.
At the current price of 51.71, Zoetis Inc. has a dividend yield of 0.74%. We see a return on equity of 32.60%.
Looking more long-term Zoetis Inc., is projected to get an EPS growth for the next five years of 12.58%. In the short-term an EPS growth of 23.09% in the next year is forecasted. This is after a EPS growth of -41.90% for this year and for the last five years a 25.10% growth has been seen.